SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-21-029811
Filing Date
2021-05-25
Accepted
2021-05-25 17:05:41
Documents
5
Period of Report
2021-07-21

Document Format Files

Seq Description Document Type Size
1 PRE 14A ljpc-pre14a_20210721.htm PRE 14A 1075952
2 GRAPHIC ge3wi1myvkti000003.jpg GRAPHIC 52430
3 GRAPHIC ge3wi1myvkti000004.jpg GRAPHIC 65813
4 GRAPHIC ge3wi1myvkti000002.jpg GRAPHIC 5499
5 GRAPHIC ge3wi1myvkti000001.jpg GRAPHIC 5499
  Complete submission text file 0001564590-21-029811.txt   1255529
Mailing Address 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE, SUITE 240 SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36282 | Film No.: 21961588
SIC: 2836 Biological Products, (No Diagnostic Substances)